Healthy microbiome-moving towards functional interpretation

Area of Science:

• Microbiome research
• Computational biology
• Metagenomics

Background:

• Microbiome-based disease prediction offers noninvasive health markers.
• Current indices often rely on species richness and taxonomic classification.
• Metabolism-centric approaches reveal limitations of taxonomy-reliant methods.

Purpose of the Study:

• To introduce a novel metagenomic health index (Q2PD) for distinguishing healthy and unhealthy microbiomes, focusing on inflammatory bowel disease (IBD).
• To shift from traditional phylogenetic classification to a holistic consideration of metabolic functional potential and ecological interactions.
• To compare Q2PD's performance against existing indices like Gut Microbiome Health Index (GMHI) and hiPCA.

Main Methods:

• Developed a new metagenomic health index (Q2PD) focusing on metabolic functional potential.
• Compared Q2PD with GMHI, hiPCA, and Shannon entropy on IBD cohorts.
• Retrained and validated Q2PD on 27 additional datasets across diverse clinical conditions.
• Benchmarked Q2PD against GMHI and hiPCA on a longitudinal COVID-19 cohort.

Main Results:

• Q2PD demonstrated superior performance in distinguishing healthy vs. IBD states compared to existing methods.
• The index successfully validated across 27 diverse clinical datasets.
• Q2PD outperformed GMHI and hiPCA on a longitudinal COVID-19 cohort.
• The method showed robustness to varying sequencing depths.

Conclusions:

• Advocates for a shift towards functional metagenomic approaches for microbiome health assessment.
• Highlights the potential of Q2PD for understanding and assessing microbiome health.
• Q2PD is freely available, promoting further research and development.